Surgical Infections· 2012Q2
Disseminated <i>Nocardia farcinica</i> : Literature Review and Fatal Outcome in an Immunocompetent Patient
- 69citations
- Q2SCImago
- 2012year
Short summary
Disseminated Nocardia farcinica, typically linked to immunocompromise (88% of cases with malignancy or autoimmune disease), can be fatal even in immunocompetent individuals, as demonstrated by a case of sepsis with lung and synovium infection.
AI-generated from the title and abstract; the full text is not read.
Key points
- Disseminated Nocardia farcinica is strongly associated with underlying malignancy or autoimmune disease (88% of patients).
- A fatal case of N. farcinica sepsis occurred in an immunocompetent patient with no known risk factors.
- Post-mortem cultures from lung and synovium confirmed N. farcinica infection, correlating with bronchopneumonia and synovitis.
- The mortality rate for N. farcinica in recent literature is 39%, an increase from earlier reports.
AI-generated from the title and abstract; the full text is not read.
Abstract
BACKGROUND: Nocardia farcinica is a gram-positive, partially acid-fast, methenamine silver-positive aerobic actinomycete. Nocardia spp. are opportunistic pathogens, and N. farcinica is the least common species of clinical importance. METHODS: Review of the recent literature and description of a immunocompetent patient with no known risk factors who contracted fatal N. farcinica sepsis. RESULTS: Positive pre-mortem and post-mortem cultures from the lung and synovium correlated with acute bronchopneumonia and synovitis at autopsy. Colonies of filamentous bacteria, which were not apparent in conventional hematoxylin and eosin-stained sections, were observed with gram and methenamine silver stains, but acid-fast stains were negative. A literature review revealed that disseminated N. farcinica often is associated with an underlying malignant tumor or autoimmune disease (88% of patients). Chemotherapy or corticosteroid treatments are additional risk factors. CONCLUSIONS: Trimethoprim-sulfamethoxazole typically is the first-line therapy for N. farcinica; treatment with amikacin and imipenem-cilastatin is used less often (7% of patients). Despite aggressive therapy, we observed that the death rate (39%) associated with N. farcinica in recent publications was eight percentage points higher than reported in a review from 2000.
The authors' abstract, as published at the source. Surgical Infections, 2012 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Microbiology
MicrobiologyMedicine